Assessment of the immune response to tumors is growing in importance as the prognostic
implications of this response are increasingly recognized, and as immunotherapies are …

Three randomized phase III trials have now conclusively proven that exposure to a PD-1
inhibitor prolongs survival in recurrent/metastatic (R/M) HNSCC, and it is clear that such …

Immunogenic cell death (ICD) has been classified as a form of regulated cell death (RCD)
that is sufficient to activate an adaptive immune response. Accumulating evidence has …

Different immunotherapeutic approaches have proved to be of significant clinical value to
many patients with different types of advanced cancer. However, we need more precise …

Head and neck squamous cell carcinoma (HNSCC) represents a group of tumors arising in
the oral cavity, oropharynx, and larynx. Although HNSCC is traditionally associated with …

Head and Neck cancer is among the most common cancers worldwide, with a high
prevalence in south East Asia, Brazil and central Europe. Head and Neck Squamous cell …

The head and neck district represents one of the most frequent sites of cancer, and the
percentage of metastases is very high in both loco-regional and distant areas. Prognosis …

Although m6A modifications are associated with tumor progression, and anti-tumor immune
responses, the role of m6A regulators in HPV-related carcinogenesis has not been well …

Laryngeal carcinoma is the second common malignancy of the upper aerodigestive tract
after lung cancer; in most cases is a squamous cell carcinoma, whose risk factors include …

Purpose This study evaluated the role of anti-tumor immune response of curcumin on
tongue squamous cell carcinama (TSCC). Experimental design Cell lines (Cal 27, FaDu) …